Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | CA9 | Q16790 | 1/20 | 0.55 |
| ▸ | PGR | P06401 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | FKBP4 | Q02790 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL701742 | 1.00 | CA1 (0.55) | CA1CA9PGRALDH1A1LMNA | |
| Butyrolactone SCHEMBL22367208 | 0.93 | CA1 (0.48) | CA1CA9ALDH1A1LMNATP53 | |
| Bicarbonate SCHEMBL27877696 | 0.86 | CA1 (0.59) | CA1CA9PGRALDH1A1LMNA | |
| Pyruvate SCHEMBL28404329 | 0.85 | CA1 (0.64) | CA1CA9PGRALDH1A1LMNA | |
| Acetic Acid SCHEMBL27560595 | 0.85 | CA1 (0.70) | CA1CA9PGRALDH1A1LMNA | |
| Oxalic Acid SCHEMBL31339544 | 0.83 | CA1 (0.73) | CA1CA9PGRALDH1A1LMNA | |
| Acetic Acid SCHEMBL28267793 | 0.83 | CA1 (0.73) | CA1CA9PGRALDH1A1LMNA | |
| Acetone SCHEMBL27767208 | 0.83 | CA1 (0.73) | CA1CA9PGRALDH1A1LMNA | |
| Methacrylic Acid SCHEMBL5815522 | 0.82 | CA1 (0.59) | CA1CA9PGRALDH1A1LMNA | |
| Methacrylic Acid SCHEMBL36254 | 0.82 | CA1 (0.59) | CA1CA9PGRALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11793911-B2 | Stent made of a bio-degradable magnesium alloy with a magnesium fluoride coating and an organic coating | MEKO LASERSTRAHL-MATERIALBEARBEITUNGEN E.K. (DE) | 2023-10-24 | — | — | US | claimed |
| US-11167065-B2 | Shellac and paclitaxel coated catheter balloons | EUROCOR TECH GMBH (DE) | 2021-11-09 | — | — | US | claimed |
| US-20200139017-A1 | STENT MADE OF A BIO-DEGRADABLE MAGNESIUM ALLOY WITH A MAGNESIUM FLUORIDE COATING AND AN ORGANIC COATING | MEKO LASERSTRAHL-MATERIALBEARBEITUNGEN E.K. (DE) | 2020-05-07 | — | — | US | claimed |
| EP-3562526-A1 | STENT MADE OF A BIO-DEGRADABLE MAGNESIUM ALLOY WITH A MAGNESIUM FLUORIDE COATING AND AN ORGANIC COATING | MeKo Laserstrahl-Materialbearbeitungen e.K. (DE) | 2019-11-06 | — | — | EP | claimed |
| US-20190275211-A1 | SHELLAC AND PACLITAXEL COATED CATHETER BALLOONS | EUROCOR TECH GMBH (DE) | 2019-09-12 | — | — | US | claimed |
| EP-1718347-B1 | BIOCOMPATIBLE COATING, METHOD, AND USE OF MEDICAL SURFACES | HEMOTEQ AG (DE) | 2017-03-08 | — | — | EP | claimed |
| US-9522219-B2 | Resorbable stents which contain a magnesium alloy | HEMOTEQ AG (DE) | 2016-12-20 | — | — | US | claimed |
| EP-1881853-B1 | ALL-OVER COATING OF VESSEL STENTS | HEMOTEQ AG (DE) | 2016-09-28 | — | — | EP | claimed |
| EP-2421572-B1 | SHELLAC AND PACLITAXEL COATED CATHETER BALLOONS | BIOSENSORS EUROP S A (CH) | 2016-08-31 | — | — | EP | claimed |
| EP-2114481-B1 | BIODEGRADABLE VASCULAR SUPPORT | HEMOTEQ AG (DE) | 2015-09-30 | — | — | EP | claimed |
| US-20120143132-A1 | SHELLAC AND PACLITAXEL COATED CATHETER BALLOONS | EUROCOR GMBH (DE) | 2012-06-07 | — | — | US | claimed |
| EP-2421572-A2 | SHELLAC AND PACLITAXEL COATED CATHETER BALLOONS | Eurocor GmbH (DE) | 2012-02-29 | — | — | EP | claimed |
| US-20110076319-A1 | BIORESORBABLE METAL STENT WITH CONTROLLED RESORPTION | EUROCOR GMBH (DE) | 2011-03-31 | — | — | US | claimed |
| WO-2010121840-A2 | SHELLAC AND PACLITAXEL COATED CATHETER BALLOONS | EUROCOR GMBH (DE) | 2010-10-28 | — | — | WO | claimed |
| EP-2243501-A1 | Shellac and paclitaxel coated catheter balloons | Eurocor Gmbh (DE) | 2010-10-27 | — | — | EP | claimed |
| US-20100145266-A1 | METHOD FOR LOADING STRUCTURED SURFACES | EUROCOR GMBH (DE) | 2010-06-10 | — | — | US | claimed |
| US-20100076544-A1 | BIODEGRADABLE VASCULAR SUPPORT | HEMOTEQ AG (DE) | 2010-03-25 | — | — | US | claimed |
| US-20100076542-A1 | COATED EXPANDABLE SYSTEM | EUROCOR GMBH (DE) | 2010-03-25 | — | — | US | claimed |
| EP-1435877-B1 | COATING OF STENTS FOR PREVENTING RESTENOSIS | HEMOTEQ AG (DE) | 2009-04-15 | — | — | EP | claimed |
| EP-1501566-B1 | MEDICAL PRODUCTS COMPRISING A HAEMOCOMPATIBLE COATING, PRODUCTION AND USE THEREOF | HEMOTEQ AG (DE) | 2008-08-13 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110076319-A1 | BIORESORBABLE METAL STENT WITH CONTROLLED RESORPTION | ESRRB, NR3C2, ESRRA | CA1 600/4885CA9 1223/4885PGR 11/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.